Article 24 Aug 2026 FTC Announces Proposed Enforcement Policy Statement Regarding “Personalized Pricing,” Signals Potential Scrutiny Of The Use Of Consumer Personal Information In Pricing United States Consumer
Article 13 Aug 2026 FDA’s Proposed GRAS Rule: Mandatory Notifications, Expanded Scope, And Open Questions United States Healthcare
Article 03 Aug 2026 FDA Advisory Committee Recommends Several Peptides For Compounding For Various Uses Despite Staff Opposition: What Stakeholders Need To Know United States Healthcare
Article 31 Jul 2026 “Junk Fees” Summer 2026 Roundup Part 2 – State AG Enforcement On Fee Practices United States Consumer
Article 23 Jul 2026 “Junk Fees” Summer 2026 Roundup Part 1 – Illinois, NYC, And DC United States Consumer
Article 17 Jul 2026 When “Just Send The Records” Isn’t Simple - Lessons From The FTC’s Amazon FCRA Settlement (Podcast) United States Consumer
Article 16 Jul 2026 Summer 2026 Autorenewal Roundup: NYC and Louisiana Enact New Regulatory Requirements United States Consumer
Article 03 Jul 2026 When “Just Send The Records” Isn’t Simple: Lessons From The FTC’s Amazon FCRA Settlement United States Consumer
Article 13 May 2026 FDA Signals Increased Cosmetics Oversight Through MoCRA Implementation And Other Regulatory Efforts United States Media & IT
Article 06 May 2026 FDA Turns Up The Heat On GLP 1 Dupes Sold “For Research Use Only,” Finds Intended Use Suggests Otherwise (Podcast) United States Healthcare
Article 28 Apr 2026 From MAHA To Market - FDA And Some Retailers Announcing New Policies On Colors (Podcast) United States Media & IT
Article 14 Apr 2026 FDA Turns Up The Heat On GLP 1 Dupes Sold "For Research Use Only," Finds Intended Use Suggests Otherwise United States Media & IT
Article 27 Mar 2026 From MAHA To Market: FDA And Some Retailers Announcing New Policies On Colors United States Healthcare
Article 26 Mar 2026 FDA MAHA Updates: "No Artificial Color” Claims And A New Preservative Safety Reassessment United States Healthcare
Article 23 Mar 2026 Fifth Circuit Vacates FTC’s Cease-and-Desist Order Against Intuit, Holding Internal Adjudication Of Deceptive Advertising Claims Unconstitutional United States Media & IT